Skip to main content

3 Result(s)

within A P Haynes Remove this filter

and

  1. Article

    Open Access

    Long-term survival after treatment for Hodgkin’s disease (1973–2002): improved survival with successive 10-year cohorts

    The Nottinghamshire Lymphoma Registry contains the details of all the patients diagnosed with lymphoma (since 1 January 1973) within a defined geographical area with a population of 1.1 million. It was therefo...

    E M Bessell, G Bouliotis, S Armstrong, J Baddeley, A P Haynes… in British Journal of Cancer (2012)

    Download PDF (299 KB) View Article

  2. No Access

    Article

    Caspase-independent killing of Burkitt lymphoma cell lines by rituximab

    Caspase-independent cell death may have a critical role to play in the therapeutic destruction of tumours. Recently it has been suggested that one of the mechanisms by which rituximab, a therapeutic anti-CD20 ...

    I. Daniels, A. M. Abulayha, B. J. Thomson, A. P. Haynes in Apoptosis (2006)

  3. No Access

    Article

    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

    We treated 17 patients with refractory (n=7) or relapsed lymphoid malignancy (n=10) following allogeneic HSCT with donor lymphocyte infusions (DLI). Patients with low-grade disease received DLI alone (n=7) or fol...

    N H Russell, J L Byrne, R D Faulkner, M Gilyead… in Bone Marrow Transplantation (2005)